Page 22 - Sun Pharma

Sun Pharma takes mobile app route to raise disease awareness: Abhay Gandhi

Q&A with Sun Pharma's India Business CEO

Sun Pharma launches app for asthma patients

The app will help doctors track treatment progress of patients and increase compliance to medication

Sun looks for partner in Japan

Meanwhile, the firm on Wednesday signed an deal with International Centre for Genetic Engineering and Biotechnology to develop a novel botanical drug for treatment of dengue

Sun Pharma says phase-3 trials in skin disorder drug show positive results

The drug, Tildrakizumab, is being developed by Sun Pharma under license from MNC drug major MSD

Sun Pharma partners ICGEB to develop dengue drug

The agreement permits Sun Pharma access to all the intellectual properties of the drug across 17 countrieS

Sun Pharma shares up 2% as it gets approval for non-steroid drug

The stock gained 1.74% to Rs 825.95 on BSE

Sun gets US FDA nod for eye drug

The company, which also launched ophthalmic division in US, earns about half its consolidated revenue from United States

Sun Pharma gets USFDA nod for eye inflammation drug

The drug has been developed by InSite Vision which the company had acquired in November 2015

Sun Pharma buys Novartis brands for Rs 1,900 cr

To acquire 14 Novartis drugs in Japan to boost presence in the country

Sun Pharma to sell AstraZeneca's diabetes drug in India

As part of the pact, Sun Pharma will sell AstraZeneca's dapagliflozin, a Type 2 diabetes medicine, under brand name Oxra

Sun Pharma to sell AstraZeneca's diabetes drug in India

The anti-diabetic drug, dapagliflozin, will be distributed under the brand name of 'Oxra'

Sun Pharma names Dhoni as Revital H brand ambassador

The drug major said that ace cricketer emerged as a popular choice based on consumer research conducted by the company.

SPARC gains ahead of board meet for rights issue

The stock has rallied nearly 8% to Rs 301 on the BSE ahead of the board meet on March 5 for the proposed rights issue